Stay updated on our journey! Sign up to follow Infusion51a milestones, innovations, and exciting growth opportunities in transforming fitness and wellness.
Infusion51a is committed to protecting your privacy. This Privacy Policy explains how we collect, use, and protect your information when you subscribe to our SMS campaigns.
We do not sell, rent, or share your personal information with third parties except:
We use industry-standard measures to protect your information.
By subscribing to Infusion51a SMS campaigns, you agree to these Terms of Service and our Privacy Policy.
You can unsubscribe at any time by replying STOP.
Infusion51a makes no guarantees about the accuracy or reliability of SMS content.
Infusion51a is not responsible for any damages resulting from the use of the SMS campaign service.
We may update these Terms of Service. Continued use constitutes agreement to the updated terms.
We are strong in the oncology field – our current assets address the most common and deadly types of cancer: breast, pancreatic, lung, colorectal, gastric, and glioblastoma.
Yet our portfolio is now expanding into advanced health tech, nano-robotics, AI, virtual reality, telemedicine, data distribution and governance, and other digital health solutions.
In 2023, we’ll be hosting a Demo Day in the UAE, an unparalleled networking opportunity to connect innovators with the financial resources they need to take their projects forward.
We foresee scaling to 15-20 portfolio companies in 2023-2024.
Get the best industry insights by signing up for our monthly newsletter:
Copyright © 2024 Infusion 51a, LP
Follow us:
A revolutionary brand dedicated to enhancing overall health and well-being through a unique combination of cold therapy, oxygen therapy, and fitness solutions like mobility, breathing as well as Nutrition Support etc., It’s a fitness health club not only for people who are fit body enthusiastic but also who wants to heal their mind body and soul
Precise Generics is a precision-based enterprise optimizing generic drug development and targeting companion diagnostics to enhance to provide patients and physicians with more efficient alternatives.
Vivacitas is a biopharmaceutical company using artificial intelligence technology and advanced imaging strategies to develop innovative cancer therapies.